Senior insider sale
SVP and Pres., Lilly Bio-Meds at ELI LILLY & CO — senior position signals high conviction
$7.64M
6.50K shares
What this filing means
JONSSON PATRIK plans to sell 6.50K shares of ELI LILLY & CO valued at approximately $7.64M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/17/2026ACC: 0001628280-26-057430
Officer· SVP and Pres., Lilly Bio-Meds
Since Sep 2019
6.50K
Shares to sell
$7.64M
Approx. market value
7.17K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Bonus
Stock Bonus
2/10/2025
7.17KTotal acquired7.17K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Stock Bonus Stock Bonus | 7.17K | — |
| Total | 7.17K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
6.50K
Market value
$7.64M
8/17/2026
Total
Units
6.50K
Value
$7.64M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/17/2026 | 6.50K | $7.64M | NYSE | Planned |
| Total | 6.50K | $7.64M | ||